Abbott Laboratories has expanded its manufacturing capabilities for solid-dose potent and cytotoxic products, with the installation of a dry granulation roller compactor. The new compactor is housed in a dedicated manufacturing suite at the company’s multi-product potent facility in Sligo, Ireland.   According to the company, the new roller compactor offers precise process control, measuring all product quality relevant parameters (e.g., force, gap and roll speed) online that are calibrated and ...